Alnylam Pharmaceuticals Price Target Cut to $369.00 by JP Morgan
JP Morgan cut Alnylam Pharmaceuticals' price target to $369.00 per share from $375.00.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
JP Morgan cut Alnylam Pharmaceuticals' price target to $369.00 per share from $375.00.